Gene · 4739
Papers2,045
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,045
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-resolution copy number analysis of clear cell endometrial carcinoma. | Cancer Genet | 2020 | 31678638 | PubTator, text mining | PubMed |
| Methylisothiazolinone induces apoptotic cell death via matrix metalloproteinase activation in human bronchial epithelial cells. | Toxicol In Vitro | 2020 | 31629900 | PubTator, text mining | PubMed |
| Genetic and antigenic characteristics of a human influenza C virus clinical isolate. | J Med Virol | 2020 | 31498448 | PubTator, text mining | PubMed |
| miR-363-3p inhibits migration, invasion, and epithelial-mesenchymal transition by targeting NEDD9 and SOX4 in non-small-cell lung cancer. | J Cell Physiol | 2020 | 31332786 | PubTator, text mining | PubMed |
| Long term effects of early childhood traumatic brain injury on narrative discourse gist and psychosocial functioning. | Disabil Rehabil | 2020 | 30978116 | PubTator, text mining | PubMed |
| Cortactin function in invadopodia. | Small GTPases | 2020 | 29172953 | PubTator, text mining | PubMed |
| Chondroitin: a natural biomarker with immense biomedical applications. | RSC Adv | 2019 | 35530463 | PubTator, text mining | PubMed |
| Retracted Article: Long non-coding RNA PCAT1 facilitates cell growth in multiple myeloma through an MTDH-mediated AKT/β-catenin signaling pathway by sponging miR-363-3p. | RSC Adv | 2019 | 35528923 | PubTator, text mining | PubMed |
| LncRNA CASC9 regulates cell proliferation, apoptosis and cell cycle via sponging miR-145-5p in colon cancer cells. | Transl Cancer Res | 2019 | 35117034 | PubTator, text mining | PubMed |
| Silencing NEDD9 by lentivirus-delivered shRNA inhibits the growth of BxPC-3 cells in vitro and in vivo. | Transl Cancer Res | 2019 | 35116938 | PubTator, text mining | PubMed |
| Recent advances in structural studies of the CRISPR-Cas-mediated genome editing tools. | Natl Sci Rev | 2019 | 34691893 | PubTator, text mining | PubMed |
| POSITIVE EXPRESSION OF NEDD9 IN HEAD AND NECK CANCER IS RELATED TO BETTER SURVIVAL PERIOD. | Acta Clin Croat | 2019 | 32595251 | PubTator, text mining | PubMed |
| Genomic Characterization of a Novel Gut Symbiont From the Hadal Snailfish. | Front Microbiol | 2019 | 31998265 | PubTator, text mining | PubMed |
| Composition and Diversity of CRISPR-Cas13a Systems in the Genus Leptotrichia. | Front Microbiol | 2019 | 31921024 | PubTator, text mining | PubMed |
| miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer. | Onco Targets Ther | 2019 | 31908476 | PubTator, text mining | PubMed |
| RETRACTED: Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer. | Cancers (Basel) | 2019 | 31842254 | PubTator, text mining | PubMed |
| Transcriptomic Analyses Revealed Systemic Alterations in Gene Expression in Circulation and Tumor Microenvironment of Colorectal Cancer Patients. | Cancers (Basel) | 2019 | 31835892 | PubTator, text mining | PubMed |
| Multiple Origins and Specific Evolution of CRISPR/Cas9 Systems in Minimal Bacteria (Mollicutes). | Front Microbiol | 2019 | 31824468 | PubTator, text mining | PubMed |
| ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer. | Clin Epigenetics | 2019 | 31801619 | PubTator, text mining | PubMed |
| Editorial: Tumor Microenvironment and Resistance to Current Therapies. | Front Oncol | 2019 | 31799174 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4739/papers?page=42